Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Alteogen, Inc.

Clinical trials sponsored by Alteogen, Inc., explained in plain language.

Alteogen, Inc. 196170 KOSDAQ

Biopharmaceutical company developing biosimilars and antibody drugs.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Healthy volunteers help test new Drug's safety

Knowledge-focused Completed

This early-stage study tested the safety and tolerability of a drug called ALT-BB4 in 290 healthy adults. Researchers monitored for allergic reactions and other side effects. The goal was to gather safety information, not to treat any disease.

Phase: PHASE1 • Sponsor: Alteogen, Inc. • Aim: Knowledge-focused

Last updated Jun 27, 2026 09:00 UTC